Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, 149 Rue de Sèvres, 75015, Paris, France.
NSERM U1163, Université Paris Descartes - Sorbonne Paris Cité, Institut Imagine, 149 Rue de Sèvres, 75015, Paris, France.
Br J Dermatol. 2015 Dec;173(6):1405-10. doi: 10.1111/bjd.14072. Epub 2015 Nov 4.
The notion of the individual burden associated with a disease has been introduced to determine 'disability' in the broadest sense: psychological, social, economic and physical. Subtypes of epidermolysis bullosa (EB) are rare, life-threatening, untreatable chronic genodermatoses.
To develop and validate a specific questionnaire assessing the burden on families of children with EB: Epidermolysis Bullosa Burden of Disease (EB-BoD).
Items were generated by a verbatim report from parents of children with EB. Subsequently, a study was implemented for psychometric analysis. An epidermolysis bullosa burden-of-disease questionnaire was refined via item reduction according to inter-question correlations, consensus among experts and exploratory factor analysis. Internal consistency was determined by calculating Cronbach's α. Concurrent validity was determined by calculating the correlation between EB-BoD and the Short-Form 12 items (SF-12) questionnaire.
From a primary list of 30 items, EB-BoD was reduced to a 20-item questionnaire, covering four disease aspects based on the exploratory factor analysis. Construct validity was demonstrated and the EB-BoD questionnaire showed good internal consistency (Cronbach's α = 0·9). The resulting EB-BoD score was significantly correlated to the mental dimension of SF-12 (r = -0·61), but it was not correlated to it's physical dimension (r = 0·04). EB-BoD scores were significantly discriminating between EB subtypes.
The EB-BoD questionnaire appears to be a useful assessment tool regarding medical and socioeconomic issues in patients with EB and their families. EB-BoD scores correlate well with the family/parental burden experienced by the families of patients with EB.
个体疾病负担的概念被引入,以确定最广义的“残疾”:心理、社会、经济和身体。大疱性表皮松解症(EB)是罕见的、危及生命的、无法治疗的慢性遗传性皮肤病。
开发和验证一种专门评估 EB 患儿家庭负担的问卷:大疱性表皮松解症疾病负担(EB-BoD)。
项目由 EB 患儿的父母逐字报告生成。随后,进行了一项心理测量学分析研究。根据问题间的相关性、专家共识和探索性因素分析,对 EB 疾病负担问卷进行了项目删减,以完善问卷。采用 Cronbach's α 计算内部一致性。通过计算 EB-BoD 与简明健康调查问卷 12 项(SF-12)问卷的相关性来确定同时效度。
从最初的 30 项清单中,EB-BoD 被简化为 20 项问卷,涵盖了根据探索性因素分析确定的四个疾病方面。验证了结构效度,EB-BoD 问卷具有良好的内部一致性(Cronbach's α=0.9)。EB-BoD 评分与 SF-12 的心理维度显著相关(r=-0.61),但与身体维度不相关(r=0.04)。EB-BoD 评分可显著区分 EB 亚型。
EB-BoD 问卷似乎是评估 EB 患者及其家庭医疗和社会经济问题的有用工具。EB-BoD 评分与 EB 患者家庭所经历的家庭/父母负担密切相关。